Cabozantinib Response in ETV6-NTRK3 G623R Positive Carcinoma HIPO-021

ABSTRACT: We report a case of marked response to cabozantinib in a secondary entrectinib-resistant tumor harboring the ETV6-NTRK3 fusion with a G623R solvent-front mutation.

PROVIDER: EGAS00001004494 | EGA |

REPOSITORIES: EGA